Grosset, D. G., Tyrrell, E. G. and Grosset, K. A. (2014) “Switch from abobotulinumtoxinA (Dysport®) to incobotulinumtoxinA (Xeomin®) botulinum toxin formulation: a review of 257 cases”., Journal of Rehabilitation Medicine, 47(2), pp. 183–186. doi: 10.2340/16501977-1895.